Cargando…

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure

Purpose: Metabolic impairment is one key contributor to heart failure (HF) pathogenesis and progression. The major causes of HF, coronary heart disease (CHD), dilated cardiomyopathy (DCM), and valvular heart disease (VHD) remains poorly characterized in patients with HF from the view of metabolic pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chang, Li, Ruihua, Liu, Yang, Li, Zhenguo, Sun, Yujiao, Yin, Peiyuan, Huang, Rihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856915/ https://www.ncbi.nlm.nih.gov/pubmed/33553267 http://dx.doi.org/10.3389/fcvm.2020.622236

Ejemplares similares

Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
por: Zhang, Shenghui, et al.
Publicado: (2023)

The impact of valvular heart disease in patients with chronic coronary syndrome
por: Molenaar, Mitchel A., et al.
Publicado: (2023)

Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK
por: Marciniak, Anna, et al.
Publicado: (2017)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Impact of severe valvular heart disease in adult congenital heart disease patients
por: Graziani, Francesca, et al.
Publicado: (2022)

Editorial: Multimodality Imaging in Valvular Heart Disease
por: Treibel, Thomas A., et al.
Publicado: (2021)

Tricuspid Annulus Dilation in Patients With Combined Functional Tricuspid Regurgitation and Left-Heart Valvular Disease: Does Septal Annulus Not Dilate?
por: Teng, Peng, et al.
Publicado: (2022)

Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease
por: Jover, Eva, et al.
Publicado: (2022)

Cardiac Computed Tomography: Application in Valvular Heart Disease
por: Patel, Kush P., et al.
Publicado: (2022)

Editorial: Multimodality imaging in the evaluation of valvular heart disease
por: Morris, Daniel A., et al.
Publicado: (2022)

Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure
por: Curio, Jonathan, et al.
Publicado: (2023)

Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study
por: Huang, Xinghe, et al.
Publicado: (2021)

The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases
por: Tadic, Marijana, et al.
Publicado: (2021)

Considerations of valvular heart disease in children with ventricular assist devices
por: Si, Ming-Sing, et al.
Publicado: (2023)

Heart team consultations for patients with severe coronary artery disease or valvular heart disease in the era of the COVID-19 pandemic: a single-center experience
por: Jonik, Szymon, et al.
Publicado: (2023)

Valvular heart disease in pregnancy
por: Anthony, John, et al.
Publicado: (2016)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
por: Yang, Juntao, et al.
Publicado: (2023)

Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward
por: Kubala, Maciej, et al.
Publicado: (2022)

Editorial: Advances in the imaging and treatment of valvular heart disease: “rising to the challenge”
por: Banovic, Marko, et al.
Publicado: (2023)

Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study
por: Bae, SungA, et al.
Publicado: (2023)

Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease
por: Zhang, Yingyue, et al.
Publicado: (2021)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
por: Zhu, Xiyu, et al.
Publicado: (2020)

Shared Decision-Making and Patient-Reported Outcome Measures in Valvular Heart Disease
por: Saeed, Sahrai, et al.
Publicado: (2022)

Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis
por: Torres, Renato Pedro de Almeida, et al.
Publicado: (2021)

Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease
por: Tan, Juntao, et al.
Publicado: (2022)

Sex related differences in the characteristics and outcomes of heart failure: A sub analysis of heart failure disease management study
por: Grupper, Avishay, et al.
Publicado: (2022)

Effects of early phase 1 cardiac rehabilitation on cardiac function evaluated by impedance cardiography in patients with coronary heart disease and acute heart failure
por: Wang, Yishu, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Coronary microvascular dysfunction in heart failure patients
por: Toya, Takumi, et al.
Publicado: (2023)

Development and validation of a clinical predictive model for 1-year prognosis in coronary heart disease patients combine with acute heart failure
por: Huang, Xiyi, et al.
Publicado: (2022)

Case report: Successful percutaneous extracorporeal magnetic levitation ventricular assist device support in a patient with left heart failure due to dilated cardiomyopathy
por: Li, Ping, et al.
Publicado: (2023)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
por: Gao, Jie, et al.
Publicado: (2022)

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients
por: Rosa, Vitor Emer Egypto, et al.
Publicado: (2021)

Association of age at menarche with valvular heart disease: An analysis based on electronic health record (CREAT2109)
por: Sun, Zhiyu, et al.
Publicado: (2023)

The Role of the VEGF Family in Coronary Heart Disease
por: Zhou, Yan, et al.
Publicado: (2021)

Cellular Phenotypic Transformation in Heart Failure Caused by Coronary Heart Disease and Dilated Cardiomyopathy: Delineating at Single-Cell Level
por: Zhu, Luojiang, et al.
Publicado: (2022)

CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure
por: Zhang, Mao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gjghsfuptj6lmn9cf0s84alg7d